I now have comprehensive information from Goldman-Cecil Medicine, the management algorithm image, and supplementary antidote content. Let me compile the complete answer.
General Lines of Management of Acute Poisoning
The management of acute poisoning follows a structured, stepwise approach regardless of the specific toxin. The framework below is based on Goldman-Cecil Medicine (Chapter 96 — Nelson & Calello).
1. Initial Assessment & Diagnosis
History — gather:
- Toxicant(s) involved (name, estimated amount, formulation)
- Time and route of exposure (ingestion, inhalation, dermal, injection)
- Symptoms onset and progression
- Treatment already given
- Available medications at home (patient's, family's)
- Occupational/avocational exposures
The history may be incomplete or inaccurate if the patient is confused or suicidal; corroborate with relatives, EMS, and scene findings.
Physical Examination — focus on:
- Vital signs (BP, HR, RR, temperature, GCS)
- Eyes (pupils: miosis = opioid/cholinergic; mydriasis = anticholinergic/adrenergic)
- Neurologic (level of consciousness, tone, reflexes, seizures)
- Cardiopulmonary (arrhythmia, bronchospasm, pulmonary edema)
- GI (bowel sounds, vomiting, abdominal pain)
- Skin (diaphoresis, flushing, color, burns)
Toxidromes — recognize characteristic clusters:
| Toxidrome | Features | Example Agents |
|---|
| Opioid | Miosis, coma, respiratory depression | Heroin, fentanyl, morphine |
| Anticholinergic | Mydriasis, dry flushed skin, tachycardia, urinary retention, delirium | Atropine, TCAs, antihistamines |
| Cholinomimetic | SLUDGE (salivation, lacrimation, urination, defecation, GI cramps, emesis) + bradycardia, miosis, bronchospasm | Organophosphates, carbamates |
| Adrenergic | Mydriasis, hypertension, tachycardia, hyperthermia, diaphoresis | Cocaine, amphetamines |
| Sedative-hypnotic | CNS depression, slurred speech, ataxia | Benzodiazepines, barbiturates |
Laboratory:
- Blood glucose (always), ABG/VBG, electrolytes, renal/hepatic function, CBC, coagulation
- Anion gap and osmol gap (screen for toxic alcohols)
- ECG (QRS widening → TCAs; QTc prolongation → many agents)
- Specific levels where indicated (paracetamol, salicylates, digoxin, ethanol, lithium, iron, carbamazepine)
- Urine toxicology screen (qualitative, limited specificity)
2. Stabilization (ABC + ALS)
Airway:
- Protect the airway; intubate if necessary to correct or prevent:
- Hypoxemia
- Respiratory acidosis
- Pulmonary aspiration
Breathing: Supplemental O₂; assisted ventilation as needed.
Circulation: IV access × 2; cardiac monitoring; correct hypotension with IV fluids; vasopressors if refractory.
ALS Modifications (toxin-specific):
- Atropine is often ineffective for bradycardia due to β-adrenergic receptor antagonists (BARAs), calcium-channel antagonists (CCAs), or cardiac glycosides
- Benzodiazepines for cocaine-induced tachycardia/agitation and seizures
- Calcium for CCAs, hydrofluoric acid, hypermagnesemia
- Glucagon for BARAs and CCAs
- Digoxin-specific Fab for cardiac glycoside toxicity
- High-dose insulin-glucose for BARAs and CCAs
- NaHCO₃ for myocardial sodium-channel blockers (TCAs, flecainide)
- Nitroprusside for drug-induced hypertension
- Phentolamine to reverse cocaine-induced α-adrenergic effects
- Avoid BARAs in cocaine-induced ischemia
Glucose — give IV dextrose for any altered consciousness with hypoglycaemia; precede with thiamine 100 mg IV if alcoholism suspected.
"Coma cocktail" (dextrose, thiamine, naloxone, flumazenil) — empirical use is rarely helpful and may be harmful in polydrug overdose; use only when there is strong suspicion of a specific agent.
3. Decontamination
Decontamination can be performed simultaneously with stabilization.
A. Oral (Gastrointestinal) Decontamination
1. Activated Charcoal (AC) — 1 g/kg body weight (max 100 g)
- Indications: Toxin with potential for serious toxicity that adsorbs to charcoal; ideally within 1 hour of ingestion (though benefit may extend to 2 hours for some agents)
- Contraindications: Unprotected airway; bowel obstruction or perforation; ingestion of pure aliphatic hydrocarbons or caustics; altered consciousness without secured airway
2. Gastric Emptying (Orogastric Lavage)
- Use large-bore orogastric tube; alternatively, nasogastric tube aspiration for liquid toxins
- Indications: Toxins non-adsorbent to AC with potential for consequential toxicity; ideally performed ≤1 hour post-ingestion
- Contraindications: Unprotected airway; ingestion of sharp objects; bleeding diathesis; same contraindications as AC; caustics
Ipecac-induced emesis is no longer recommended.
3. Whole Bowel Irrigation (WBI)
- Polyethylene glycol (PEG) solution at 500 mL/hour orally or via NGT, titrated to 2000 mL/hour, continued until rectal effluent clears
- Indications: Iron; sustained-release/enteric-coated medications; agents not adsorbed by AC; body packers (drug smugglers)
- Contraindications: Bowel perforation, obstruction, hemorrhage; hemodynamic or respiratory instability
B. Dermal Decontamination
- Remove contaminated clothing
- Wash thoroughly with soap and water
C. Ocular Decontamination
- Irrigate copiously with 0.9% normal saline
4. Antidotes
Few toxicants have specific antidotes. Their use does not replace the need for ongoing supportive care.
| Antidote | Indication |
|---|
| Naloxone | Opioid overdose (0.4–2 mg IV; repeat every 2–3 min; infusion at 0.8 mg/kg/hr) |
| Flumazenil | Benzodiazepine overdose (0.2 mg/min IV; max 1 mg) — caution in TCA co-ingestion/chronic BZD users |
| N-acetylcysteine (NAC) | Paracetamol (acetaminophen) overdose |
| Atropine + pralidoxime | Organophosphate/carbamate toxicity |
| Digoxin-specific Fab | Digoxin/cardiac glycoside toxicity |
| Physostigmine | Anticholinergic toxidrome (select cases) |
| Fomepizole | Methanol/ethylene glycol poisoning |
| Hydroxocobalamin | Cyanide poisoning |
| Calcium gluconate | Calcium-channel blocker / HF / hypermagnesemia |
| Glucagon | Beta-blocker / calcium-channel blocker |
| Edetate calcium disodium (CaNa₂EDTA) | Lead poisoning |
| Octreotide | Sulfonylurea-induced hypoglycaemia |
| Sodium bicarbonate | TCA / Na-channel blocker toxicity |
| Pyridoxine (B₆) | Isoniazid overdose |
| Methylene blue | Methaemoglobinaemia |
| Deferoxamine | Iron poisoning |
5. Enhanced Elimination
Used when the toxin is absorbed and elimination needs to be accelerated.
A. Multiple-Dose Activated Charcoal (MDAC)
- Average dose: 12.5 g every 4–6 hours (after initial 1 g/kg loading dose)
- Works via: interruption of enterohepatic/enteroenteric recirculation; "GI dialysis"
- Definite benefit: Carbamazepine, dapsone, phenobarbital, quinine, salicylates, theophylline
- Potential benefit: Amitriptyline, digitoxin, digoxin, phenytoin, sotalol, nadolol, piroxicam
- Contraindications: Same as single-dose AC
B. Urinary Alkalinization
- IV sodium bicarbonate to achieve urine pH 7.5–8.5
- Indications: Chlorpropamide, 2,4-dichlorophenoxyacetic acid, formic acid, methotrexate, phenobarbital, salicylates
- Contraindications: Volume overload, pulmonary oedema, cerebral oedema
C. Extracorporeal Removal
- Consider when patient is hemodynamically stable (instability may preclude use)
- Modalities: haemodialysis, haemoperfusion, haemofiltration, exchange transfusion, plasmapheresis
- Indications: Lithium, salicylates, methanol, ethylene glycol, theophylline, valproate (see specific extracorporeal criteria)
6. Disposition & Psychiatric Review
- All cases of intentional self-poisoning require psychiatric assessment before discharge
- Recurrent purposeful self-poisoning rate is 12–18%, with most events within 3 months
- Risk-stratify for ICU admission vs. monitored ward vs. discharge with follow-up
- Notify the Poison Control Centre where available — they provide real-time management guidance and collect data
Source: Goldman-Cecil Medicine, International Edition — Chapter 96: Acute Poisoning (Nelson LS, Calello DP), pp. 1111–1124.